FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Planning Guidance on Clinical Trial Modernization

[ Price : $8.95]

CDER Office of Compliance director Don Ashley tells a regulatory conference that the Center is planning a guidance document on the...

FDA Denies Petition on Colonoscopy Preparation

[ Price : $8.95]

FDA denies a Braintree citizen petition that asked it not to approve a tablet-based or tablet-containing colonoscopy preparation u...

Guide on Monkeypox Diagnostic Tests

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Policy for Monkeypox Tests To Address the Public Health Eme...

Proposed OTC Contraceptive Heads to Panel

[ Price : $8.95]

Federal Register notice: FDA announces an 11/18 joint advisory committee meeting to discuss a Laboratoire HRA Pharma supplemental ...

Streamlined GMP Requirements for Combo Products

[ Price : $8.95]

Federal Register notice: FDA finalizes a list of alternative or streamlined mechanisms for complying with GMP requirements for com...

Guidance for Computer Software Assurance for Devices

[ Price : $8.95]

FDA publishes a draft guidance entitled Computer Software Assurance for Production and Quality System Software that the agency say...

FDA Approves BMS Plaque Psoriasis Drug

[ Price : $8.95]

FDA approves a Bristol Myers Squibb NDA for plaque psoriasis drug Sotyktu (deucravacitinib), a first-in-class, oral, selective, al...

Biomarin Reports Leukemia in Patient on Gene Therapy

[ Price : $8.95]

BioMarin Pharmaceutical tells FDA a patient participating in the companys hemophilia A Phase 3 gene therapy trial of valoctocogene...

2nd Time a Charm in ALS Drug Panel Vote

[ Price : $8.95]

In an unusual second advisory committee meeting in six months, panel members reverse their March vote and recommend approval for A...

Nominations Sought for Device Panels

[ Price : $8.95]

Federal Register notice: FDA seeks nominations for voting members to serve on CDRHs Medical Devices Advisory Committee device pane...